Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Xinyu Nan"'
Autor:
Qi Sun, Fang Liu, Jiakang Fang, Qiangqiang Lian, Yunpeng Hu, Xinyu Nan, Fa-Ming Tian, Guochuan Zhang, Dianwen Qi, Liu Zhang, Jingwen Zhang, Yang Luo, Zuzhuo Zhang, Zhuang Zhou
Publikováno v:
Bone Reports, Vol 20, Iss , Pp 101744- (2024)
Objectives: Adjacent segment disc degeneration (ASDD) is one of the long-term sequelae of spinal fusion, which is more susceptible with osteoporosis. As an anti-osteoporosis drug, strontium ranelate (SR) has been reported to not only regulate bone me
Externí odkaz:
https://doaj.org/article/ba3b0ee4b3e746b4a3addb57ce6a5c25
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
BackgroundThe establishment of rodent models, such as rat and mouse models, plays a critical role in the study of diabetic associated cognitive decline. With the continuous growth of relevant literature information, it is difficult for researchers to
Externí odkaz:
https://doaj.org/article/fe787576b51749f1b108acc53a409f39
Publikováno v:
Frontiers in Aging Neuroscience, Vol 14 (2022)
BackgroundDiabetes-associated cognitive impairment (DACI) is a common complication of diabetes, and studies have shown that DACI is more severe in postmenopausal patients with diabetes. Forsythoside B (FTS⋅B) can inhibit inflammation and reduce syn
Externí odkaz:
https://doaj.org/article/9b734917389d4825ab6ab5d4c24addd4
Autor:
Lawrence Rice, Swaminathan P. Iyer, Cesar Gentille, Sai Ravi Pingali, Qian Qin, Alexandria T. Phan, Christopher Leveque, Joe Ensor, Xinyu Nan
Publikováno v:
Leukemia & Lymphoma. 58:2110-2117
Hyperleukocytosis in patients with acute myeloid leukemia (AML) can lead to leukostasis, which if left untreated, has a high mortality. While prompt cytoreductive chemotherapy is essential, treatment with leukapheresis is controversial. This study in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79c0034523acfde413b2b968ce9c6d7e
https://doi.org/10.1080/10428194.2016.1277386
https://doi.org/10.1080/10428194.2016.1277386
Publikováno v:
Oncology (Williston Park, N.Y.). 32(12)
The two programmed death 1 checkpoint inhibitors nivolumab and pembrolizumab are approved by the US Food and Drug Administration as second-line treatment for recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). Based on the existing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b0a10cf2d687a5ee2c2c2a69bfa24625
https://pubmed.ncbi.nlm.nih.gov/30632130
https://pubmed.ncbi.nlm.nih.gov/30632130
Autor:
Kathryn A. Gold, Paulette Gabbai-Saldate, William Mitchell, Sandip Pravin Patel, Xinyu Nan, Lyudmila Bazhenova
Publikováno v:
Journal of Clinical Oncology. 38:e19355-e19355
e19355 Background: Immune checkpoint inhibitors (CIs) have been shown to improve overall survival in lung cancer and are FDA approved in multiple settings, both as single agents and in combination with chemotherapy. Immune related adverse events (irA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::535979b3ef054671561220af37eff838
https://doi.org/10.1200/jco.2020.38.15_suppl.e19355
https://doi.org/10.1200/jco.2020.38.15_suppl.e19355
Autor:
Andrew M. Farach, Tara N. Miller, Shruti Pandita, Swaminathan P. Iyer, Xinyu Nan, Sai Ravi Pingali, E. Brian Butler, R. A. Fisher, Bin Teh, Tej K. Pandita, Raj K. Pandita, Qian Qin
Until recently, patients with relapsed Hodgkin's lymphoma after brentuximab vedotin (Bv) treatments had poor treatment outcomes. Checkpoint inhibitors such as nivolumab and pembrolizumab that bind to and inhibit programmed cell death protein-1 (PD-1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19d653536e55732a4a0ebdc44184c470
https://europepmc.org/articles/PMC6135239/
https://europepmc.org/articles/PMC6135239/
Publikováno v:
Oncology (08909091); Dec2018, Vol. 32 Issue 12, p617-626, 5p
Autor:
Cesar Gentille Sanchez, Lawrence Rice, Xinyu Nan, Ibrahim F. Ibrahim, Yan Xing, Arthur W. Zieske, Michael Greenwood, Kelty R. Baker, Swaminathan P. Iyer, Randall J. Olsen, Sai Ravi Pingali, Brian Y. Merritt
Publikováno v:
Blood. 128:2889-2889
Background: Acute Myeloid Leukemia (AML) without favorable and particular unfavorable cytogenetic aberrations is classified as intermediate prognosis. Recurrent somatic genomic mutations through The Cancer Genome Atlas (TCGA) have provided valuable p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc86772e5ad97d8d2206ba9905b1a3ff
https://doi.org/10.1182/blood.v128.22.2889.2889
https://doi.org/10.1182/blood.v128.22.2889.2889
Autor:
John McCann, George K. Istaphanous, Andreas W. Loepke, Christopher G. Ward, Elizabeth A. Hughes, Steve C. Danzer, John J. McAuliffe, Xinyu Nan
Publikováno v:
Anesthesia and analgesia. 116(4)
Accumulating evidence indicates that isoflurane and other, similarly acting anesthetics exert neurotoxic effects in neonatal animals. However, neither the identity of dying cortical cells nor the extent of cortical cell loss has been sufficiently cha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8b8cdfbefa1eefbc18fcd2011f2c6fe
https://pubmed.ncbi.nlm.nih.gov/24187695
https://pubmed.ncbi.nlm.nih.gov/24187695